Headline Resources Clinical Trial Protocols Publications Posters Presentations Publications Filter by Filter resources by title Topic COVID-19 Ebola Matrix-M™ Adjuvant MERS Respiratory Syncytial Virus Seasonal Influenza Search resources by topic Year Filter resources by year Title Topic Year Link Document Notes Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine COVID-19 2021 View New England Journal of Medicine, Heath P.T., et. al. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice COVID-19 2021 View Nature Communications, Tian J.H., et. al. Structural Characterization and Modeling of a Respiratory Syncytial Virus Fusion Glycoprotein Nanoparticle Vaccine in Solution Respiratory Syncytial Virus 2020 View Neutron and X-ray scanning reveal structure of a candidate vaccine’s nanoparticles in a more realistic environment. Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine COVID-19 2020 View New England Journal of Medicine, Keech, Cheryl, et al Induction of Cross-reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine Seasonal Influenza 2020 View Clinical Infectious Diseases, Shinde, Vivek, et al Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate COVID-19 2020 View Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection Respiratory Syncytial Virus 2020 View Journal of Infectious Diseases, Shinde, Vivek, et al Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity Respiratory Syncytial Virus 2020 Download Vaccine, Patel, Nita, et al Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance Seasonal Influenza 2020 View Vaccine, Bruce-Staskal, Pamela J., et al Comparison of the Safety and Immunogenicity of a Novel Matrix-M-adjuvanted Nanoparticle Influenza Vaccine with a Quadrivalent Seasonal Influenza Vaccine in Older Adults: A Randomized Controlled Trial Seasonal Influenza 2020 View Disclaimer: Pre-print only and not yet published in peer-reviewed article First-in-Human Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine COVID-19 2020 Download Disclaimer: Pre-print only and not yet published in peer-reviewed article Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants Respiratory Syncytial Virus 2020 Download New England Journal of Medicine, Madhi S.A., et al SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice COVID-19 2020 Download Disclaimer: Pre-print only and not yet published in peer-reviewed article Prediction of serious RSV‐related outcomes in older adults with outpatient RSV respiratory illness during 12 consecutive seasons Respiratory Syncytial Virus 2020 View Influenza and Other Respiratory Viruses | Kieke, BA, et al. Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA Seasonal Influenza 2020 View Vaccine, Portnoff, Alyse, et al Severe Morbidity and Mortality Associated with Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults Respiratory Syncytial Virus 2018 Download Bradley Ackerson, Hung Fu Tseng, Lina S. Sy, Zendi Solano, Jeff Slezak, Yi Luo, Christine A. Fischetti, Vivek Shinde Why Making a Diagnosis of Respiratory Syncytial Virus Should Matter to Clinicians Respiratory Syncytial Virus 2018 Download Angela R. Branche, MD Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine Seasonal Influenza 2018 View New England Journal of Medicine, Shinde, Vivek, et al Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™ Matrix-M™ Adjuvant 2017 View Vaccine, LövgrenBengtsson, Karin, et al Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults Respiratory Syncytial Virus 2017 View Immun Ageing, Fries L., et al Pagination Current page 1 Page 2 Next page next › Last page last » Main navigation ABOUT US OUR PIPELINE SCIENCE AND TECHNOLOGY RESOURCES CAREERS Utility navigation FOR INVESTORS Corporate Governance Stock Information Events SEC Filings Analyst Coverage Investor Relations Contact Annual Report Investor Presentation NEWS COVID-19 Candidate Updates Press Releases & Statements Novavax in the News Join the Press Release List Press Center Contact Us CONTACT US 21 Firstfield Road Gaithersburg, MD 20878 (240) 268-2000 SOCIAL Footer navigation Privacy Policy Terms and Conditions Pay Transparency Nondiscrimination Provision Purchase Order Terms and Conditions This site uses cookies and similar technologies to provide you with our services, enhance the performance and functionality of our services, and analyze the use of our products and services. By clicking ‘Accept’ you are indicating your consent for us to place these cookies. For more information, please read our Privacy Policy or manage your cookie settings. Accept